NCT03699579已完成不适用
Patients Characteristics, Treatment Utilization, Costs and Outcomes in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) Who Received at Least One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy in Taiwan
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Ipsen
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Medication usage
研究概览
简要总结
This is a retrospective cohort study aiming to collect data on patients' characteristics, resource utilization, adverse events management and calculate costs attributed to current treatments of advance RCC patients who have received at least one prior VEGF-targeted therapy in Taiwan from National Health Insurance (NHI) perspective.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with confirmed diagnosis of clear-cell renal cell carcinoma
- •Patients with evidence of metastatic disease
- •Patients who have received at least one previous VEGFR-targeted therapy, i.e sunitinib, pazopanib or sorafenib
- •Patients who received care at the selected medical centers, utilizing the National Health Insurance (NHI) reimbursed system at the time of the disease
排除标准
- •Patients enrolled in any clinical trial involving anti-cancer therapy
- •Pregnant woman
结局指标
主要结局
Medication usage
时间窗: From start point for 2.5 months
Treatment's duration
时间窗: From start point for 2.5 months
次要结局
- Cost of medication used(From start point for 2.5 months)
- Costs of adverse event management(From start point for 2.5 months)
- Frequency of health resource usage(From start point for 2.5 months)
- Cost of health resource usage(From start point for 2.5 months)
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and OutcomesBreast CancerNCT04396626Pfizer975
已完成
不适用
Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In ColombiaAtrial FibrillationNCT04234698Pfizer2,076
已完成
不适用
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.Metastatic Breast CancerNCT04671615Pfizer559
已完成
不适用
Oxycodone User Registry (OUR)PainNCT00978328Ortho-McNeil Janssen Scientific Affairs, LLC827
撤回
不适用
Characteristics of Patients With COVID-19 in Meta State, ColombiaCOVIDSARS-CoV 2SARS PneumoniaSARS (Disease)SARS (Severe Acute Respiratory Syndrome)NCT04456426Hospital Departamental de Villavicencio